Drug delivery for traditional and emerging airway models
Drug delivery for traditional and emerging airway models
Respiratory diseases such as asthma and COPD have no cures and few new treatments. These diseases have an immutable mortality rate and impact millions of individuals worldwide. Respiratory drug development is time-consuming and costly, owing to the inability of existing models to replicate the complexity of human disease (static cell cultures and animal models). The problem is intensified through the way in which drugs are delivered to these models, which is not always representative of the human microenvironment, where different drug delivery methods (impaction, sedimentation and diffusion) target different regions of the lungs. This review describes current models of the human airways together with the range of different aerosol drug delivery methods (commercially available and in development) alongside emerging Organ on Chip technologies.
1-19
Karra, Nikita
8037beb7-98d3-40b2-9e02-51e4e917b3c0
Swindle, Emily
fe393c7a-a513-4de4-b02e-27369bd7e84f
Morgan, Hywel
de00d59f-a5a2-48c4-a99a-1d5dd7854174
Karra, Nikita
8037beb7-98d3-40b2-9e02-51e4e917b3c0
Swindle, Emily
fe393c7a-a513-4de4-b02e-27369bd7e84f
Morgan, Hywel
de00d59f-a5a2-48c4-a99a-1d5dd7854174
Karra, Nikita, Swindle, Emily and Morgan, Hywel
(2020)
Drug delivery for traditional and emerging airway models.
Organs-on-a-Chip, , [100002].
(doi:10.1016/j.ooc.2020.100002).
Abstract
Respiratory diseases such as asthma and COPD have no cures and few new treatments. These diseases have an immutable mortality rate and impact millions of individuals worldwide. Respiratory drug development is time-consuming and costly, owing to the inability of existing models to replicate the complexity of human disease (static cell cultures and animal models). The problem is intensified through the way in which drugs are delivered to these models, which is not always representative of the human microenvironment, where different drug delivery methods (impaction, sedimentation and diffusion) target different regions of the lungs. This review describes current models of the human airways together with the range of different aerosol drug delivery methods (commercially available and in development) alongside emerging Organ on Chip technologies.
Text
Drug delivery for traditional and emerging airway models
- Accepted Manuscript
More information
Accepted/In Press date: 24 February 2020
e-pub ahead of print date: 26 February 2020
Identifiers
Local EPrints ID: 438429
URI: http://eprints.soton.ac.uk/id/eprint/438429
PURE UUID: 09271f39-d6b8-4838-a48c-4a7ef92f6335
Catalogue record
Date deposited: 10 Mar 2020 17:30
Last modified: 17 Mar 2024 05:23
Export record
Altmetrics
Contributors
Author:
Nikita Karra
Author:
Hywel Morgan
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics